$3.54T
Total marketcap
$137.29B
Total volume
BTC 60.98%     ETH 8.72%
Dominance

LUMO Stock

4.34 {{ price }} 0.000000% {{change_pct}}%
Exchange
NasdaqGM
Market Cap
0
LOW - HIGH [24H]
0.0000 - 0.0000
VOLUME [24H]
0
{{ volume }}
P/E Ratio
0
Earnings per share
0

Price Chart

LUMO Financial and Trading Overview

stock price 4.34
Previous Close 3.62
Open 3.54
Bid 0 x 1300
Ask 0 x 1300
Day's Range 3.53 - 3.75
52 Week Range 2.95 - 9.56
Volume 10.01K
Avg. Volume 16.17K
Market Cap 30.23M
Beta (5Y Monthly) 0.631002
PE Ratio (TTM) N/A
EPS (TTM) 0
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 18.33

LUMO Valuation Measures

Enterprise Value -27984696
Trailing P/E N/A
Forward P/E -1.1349694
PEG Ratio (5 yr expected) -0.06
Price/Sales (ttm) 14.37516
Price/Book (mrq) 0.5765036
Enterprise Value/Revenue -13.307
Enterprise Value/EBITDA 0.866

Trading Information

Stock Price History

Beta (5Y Monthly) 0.631002
52-Week Change -44.61%
S&P500 52-Week Change 20.43%
52 Week High 9.56
52 Week Low 2.95
50-Day Moving Average 3.46
200-Day Moving Average 5.04

LUMO Share Statistics

Avg. Volume (3 month) 16.17K
Avg. Daily Volume (10-Days) 15.93K
Shares Outstanding 8.17M
Float 4.82M
Short Ratio 6.25
% Held by Insiders 38.43%
% Held by Institutions 30.03%
Shares Short 173.77K
Short % of Float 3.00%
Short % of Shares Outstanding 2.13%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) -1537.99%
Gross Margin 100.00%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -25.76%
Return on Equity (ttm) -45.68%

Income Statement

Revenue (ttm) 2.1M
Revenue Per Share (ttm) 0.25
Quarterly Revenue Growth (yoy) 522.50%
Gross Profit (ttm) 1.52M
EBITDA -32298000
Net Income Avi to Common (ttm) -30688000
Diluted EPS (ttm) -3.64
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 57.98M
Total Cash Per Share (mrq) 7.1
Total Debt (mrq) 421K
Total Debt/Equity (mrq) 0.8
Current Ratio (mrq) 12.608
Book Value Per Share (mrq) 6.418

Cash Flow Statement

Operating Cash Flow (ttm) -27787000
Levered Free Cash Flow (ttm) -17344000

Profile of

Country United States
State TX
City Austin
Address 4200 Marathon Boulevard
ZIP 78756
Phone 512 215 2630
Website https://lumos-pharma.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 33

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its primary product candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 3 clinical trial for the treatment of idiopathic pediatric growth hormone deficiency and other rare endocrine disorders. The company is headquartered in Austin, Texas.

Q&A For Stock

What is a current LUMO stock price?

LUMO stock price today per share is 4.34 .

How to purchase stock?

You can buy LUMO shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for ?

The stock symbol or ticker of is LUMO.

Which industry does the company belong to?

The industry is Biotechnology.

How many shares does have in circulation?

The max supply of shares is 0.

What is Price to Earnings Ratio (PE Ratio)?

PE Ratio is 0.00000000 now.

What was earnings per share over the trailing 12 months (TTM)?

EPS is 0 over the trailing 12 months.

Which sector does the company belong to?

The sector is Healthcare.

LUMO included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 18737.21 USD
-1
7.88B USD 18599.69 USD 18841.52 USD 7.88B USD
NASDAQ Global Market Composite NQGM 1952.45 USD
-0.14
1922.5 USD 1956.75 USD
Nasdaq Health Care IXHC 932.02 USD
-0.03
920.46 USD 933.54 USD

Stocks Related By Sector

Stocks Related By Industry

Stocks Related By Marketcap